Top 10 protagonist-inc.com Competitors

annexonbio.com

Privacy Policy Last Revised on July 23, 2020 Welcome to the Privacy Policy for Annexon Biosciences (“Privacy Policy”). This Privacy Policy describes how we collect, use and disclose information about you (“Information”) related to your use of and access to any content, applications and features made available by Annexon, Inc. (“Annexon Biosciences”, “we” or […]

adaptimmune.com

After Adaptimmune has affinity-enhanced a TCR, the company can deliver it to patients through a robust and commercialized manufacturing process.

metagentx.com

腸内細菌研究に基づいた医療・創薬を推進

elevartx.com

Lirafugratinib is a highly selective oral small molecule inhibitor of fibroblast growth factor receptor 2 (FGFR2) being developed for patients with FGFR2-driven cholangiocarcinoma (CCA) and other FGFR2-altered solid tumors1,2

dianthustx.com

Dianthus Therapeutics is harnessing the power of selectivity to advance next-generation complement therapies.

bioversys.com

Basel, Switzerland. June 4, 2024, 7am CEST     CF AMR Syndicate awarded BioVersys up to GBP 500’000 to support project addressing resistant non-tubercular mycobacteria (NTM) lung infections in people with cystic fibrosis LifeArc, Medicines Discovery Catapult and Cystic Fibrosis Trust to provide BioVersys with complementary disease specific support BioVersys’…

amgenpipeline.com

A robust pipeline leveraging state-of-the-art science and molecular engineering focused on the pursuit of transformative medicines with large effects in serious diseases. Human genetic validation is used whenever possible to strengthen the evidence base for as many of our programs as possible.

pharmaceutical-technology.com

Pharmaceutical news and in-depth feature articles on the new drug discoveries, healthcare research and development, big pharma trends and company deals.